Canlyniadau Chwilio - Paul Aisen

Mireinio'r Canlyniadau
  1. 1
    Alzheimer's disease therapeutic research: the path forward

    Alzheimer's disease therapeutic research: the path forward gan Paul Aisen

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Editorial
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Advances in Alzheimer’s Disease Drug Development

    Advances in Alzheimer’s Disease Drug Development gan Michael S. Rafii, Paul Aisen

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Recent developments in Alzheimer's disease therapeutics

    Recent developments in Alzheimer's disease therapeutics gan Michael S. Rafii, Paul Aisen

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

    Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease gan Paul Aisen, Bruno Vellas, Harald Hampel

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Symptomatic and Nonamyloid/Tau Based Pharmacologic Treatment for Alzheimer Disease

    Symptomatic and Nonamyloid/Tau Based Pharmacologic Treatment for Alzheimer Disease gan Paul Aisen, Joanne Cummings, L. S. Schneider

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Testing the Right Target and Right Drug at the Right Stage

    Testing the Right Target and Right Drug at the Right Stage gan Reisa A. Sperling, Clifford R. Jack, Paul Aisen

    Cyhoeddwyd 2011
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans

    Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans gan Paul Aisen, Ronald C. Petersen, Michael Donohue, Michael W. Weiner

    Cyhoeddwyd 2015
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review

    Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review gan Nicola Coley, Caroline Giulioli, Paul Aisen, Bruno Vellas, Sandrine Andrieu

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice

    A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice gan Takako Niikura, Elkhansa Sidahmed, Chiho Hirata‐Fukae, Paul Aisen, Yasuji Matsuoka

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease

    Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease gan Robert A. Rissman, John Q. Trojanowski, Leslie M. Shaw, Paul Aisen

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Effect of study partner on the conduct of Alzheimer disease clinical trials

    Effect of study partner on the conduct of Alzheimer disease clinical trials gan Joshua D. Grill, Rema Raman, Karin Ernström, Paul Aisen, Jason Karlawish

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding

    The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding gan Laurel Beckett, Michael Donohue, Cathy Wang, Paul Aisen, Danielle Harvey, Naomi Saito

    Cyhoeddwyd 2015
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention

    Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention gan Philip S. Insel, Elizabeth C. Mormino, Paul Aisen, Wesley K. Thompson, Michael Donohue

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Predicting the course of Alzheimer’s progression

    Predicting the course of Alzheimer’s progression gan Samuel Iddi, Dan Li, Paul Aisen, Michael S. Rafii, Wesley K. Thompson, Michael Donohue

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Aducanumab: Appropriate Use Recommendations

    Aducanumab: Appropriate Use Recommendations gan Joanne Cummings, Paul Aisen, Liana G. Apostolova, Alireza Atri, Stephen Salloway, Michael W. Weiner

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease

    PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease gan Marwan N. Sabbagh, Albert Agro, J. Simon Bell, Paul Aisen, Edward E. Schweizer, Douglas Galasko

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Aducanumab produced a clinically meaningful benefit in association with amyloid lowering

    Aducanumab produced a clinically meaningful benefit in association with amyloid lowering gan Jeffrey L. Cummings, Paul Aisen, Cynthia A. Lemere, Alireza Atri, Marwan N. Sabbagh, Stephen Salloway

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Health‐Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment

    Health‐Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment gan Carolyn W. Zhu, Mary Sano, Steven H. Ferris, Peter J. Whitehouse, Marian B. Patterson, Paul Aisen

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Effect of TTP488 in patients with mild to moderate Alzheimer’s disease

    Effect of TTP488 in patients with mild to moderate Alzheimer’s disease gan Aaron H. Burstein, Imogene Grimes, Douglas Galasko, Paul Aisen, Marwan N. Sabbagh, Adnan M.M. Mjalli

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

    Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease gan Charbel Moussa, Michaeline Hebron, Xu Huang, Jaeil Ahn, Robert A. Rissman, Paul Aisen, Raymond Scott Turner

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: